Want to see SLSN full AI Analyst Report?
SLSN Stock Chart & Stats
$0.94
$0.04(4.26%)
At close: 4:00 PM EDT
$0.94
$0.04(4.26%)
Day’s Range― - ―
52-Week Range$0.61 - $4.55
Previous CloseN/A
Volume5.30K
Average Volume (3M)50.43K
Market Cap
$67.11M
Enterprise Value$73.57
Total Cash (Recent Filing)$1.05M
Total Debt (Recent Filing)$9.41M
Price to Earnings (P/E)―
Beta1.74
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding70,647,040
10 Day Avg. Volume39,901
30 Day Avg. Volume50,427
Financial Highlights & Ratios
PEG Ratio-0.93
Price to Book (P/B)6.38
Price to Sales (P/S)1.81
P/FCF Ratio-10.51
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Growing Order BookThe approximately 8.2% increase in shipped and on-hand orders provides better forward visibility. If converted into revenue, the larger order base can support recovery, capacity utilization, and management’s expectation of stronger second-half performance.
New Product And Market ExpansionThe scalp-care launch expands Solesence beyond its existing applications and leverages its formulation technologies in an adjacent market. Broader product coverage can increase customer opportunities and reduce reliance on individual launches or categories over time.
Improved Balance SheetLower leverage and a healthier equity base improve financial resilience compared with prior stressed periods. This gives Solesence more flexibility to fund product development and operations, although meaningful debt and negative returns still constrain that benefit.
Bears Say
Revenue And Profitability DeteriorationThe reversal from prior growth and profitability indicates weaker demand conversion and execution risk. Sustained revenue contraction can reduce operating leverage, while renewed losses limit internally generated funding for innovation, capacity, and commercial expansion.
Negative Free Cash FlowPersistent negative free cash flow means accounting performance is not yet translating into sufficient cash after investment. Volatile conversion and working-capital needs may require external funding, limiting flexibility and increasing dependence on a successful earnings recovery.
Inventory Control WeaknessThe required restatements reveal weaknesses in historical financial controls and reduce confidence in reported costs and margins until remediation is proven. Additional reviews, revised allocation methods, and oversight may also consume management resources and delay reporting.
Solesence News
SLSN FAQ
What was Solesence’s price range in the past 12 months?
Solesence lowest stock price was $0.61 and its highest was $4.55 in the past 12 months.
What is Solesence’s market cap?
Solesence’s market cap is $67.11M.
When is Solesence’s upcoming earnings report date?
Solesence’s upcoming earnings report date is Nov 04, 2026 which is in 72 days.
How were Solesence’s earnings last quarter?
Solesence released its earnings results on Aug 19, 2026. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Solesence overvalued?
According to Wall Street analysts Solesence’s price is currently Overvalued.
Does Solesence pay dividends?
Solesence does not currently pay dividends.
What is Solesence’s EPS estimate?
Solesence’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Solesence have?
Solesence has 70,647,040 shares outstanding.
What happened to Solesence’s price movement after its last earnings report?
Solesence reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.319%.
Which hedge fund is a major shareholder of Solesence?
Currently, no hedge funds are holding shares in SLSN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Solesence Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
SLSN Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-22.55%
Trailing 12-Months
Company Description
Solesence
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.
SLSN Company Deck
SLSN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: materially weaker reported Q2 revenue and profitability and a significant accounting remediation (inventory costing restatements) are clear negatives that expose historical control weaknesses and distorted year-over-year comparatives. Offsetting this, management highlights tangible operational improvements (labor efficiency, OEE), a growing order book (shipped and on-hand orders up ≈8.2% year-over-year), new product launches targeting sizable addressable markets, and confident guidance for a stronger second half and full-year outperformance versus 2025. Management has committed to remediation actions and control enhancements. Overall, positives around backlog growth, product pipeline, and remediation efforts balance the near-term financial and control challenges.View all SLSN earnings summariesTechnical Analysis
Ownership Overview
5.90% Insiders
2.03% Mutual Funds
0.27% Other Institutional Investors
90.57% Public Companies and
Individual Investors